An approach to a solution of two major problems in operating Annular Phased Arrays in deep body hyperthermia is presented: an E-field sensor capable of measuring phase and amplitude at 70 MHz and the concept of a power transmission factor to determine the effective amplitude of each applicator. In the four-waveguide Phased Array operating at 70 MHz, which is in clinical use at the department of Radiotherapy of the Academic Medical Center (AMC), the incident fields of the waveguides were scanned in phase and amplitude over the complete aperture midplane, inside an elliptical and a square phantom filled with saline. As a check on the application of the superposition principle, superpositions of the incident fields were compared with the electric field in the measured interference set-ups. With all four applicators radiating at equal amplitude and in phase, the maximum difference over the complete midplane of the phantom between superimposed and measured interference scans was 20% and 10° in the elliptical phantom, and 20% and 30° in the square phantom. After having determined nominal amplitude and phase patterns by a vector probe, any interference set-up can be superimposed from measurement of the actual incident field of each applicator. Therefore, the availability of a vector sensor as described here will contribute to solve a problem of hyperthermia quality assurance: the performance evaluation of Phased Arrays.